Objective The risks of nonunion and subsidence are high in patients with bone density loss undergoing spinal fusion surgery. The internal application of recombinant human bone morphogenic protein 2 (rhBMP-2) in an interbody cage improves spinal fusion; however, related complications have been reported. Denosumab, a human monoclonal antibody targeting the receptor activator of nuclear factor kappa B ligand (RANKL), hinders osteoblast differentiation and function. Therefore, this study aimed to observe the combined effect of the local application of rhBMP-2 in a lumbar cage and systemic RANKL inhibition on postoperative spinal fusion in patients with bone density loss undergoing posterior lumbar interbody fusion (PLIF).
Methods This retrospective observational study included 251 consecutive patients with spinal stenosis who underwent PLIF at a single center between 2017 and 2021. Clinical outcomes were assessed, and radiographic evaluations included lumbar flexion, extension, range of motion, and subsidence. Statistical analyses were conducted to identify the combined effect of the treatment and the subsidence and spinal fusion status.
Results One hundred patients were included in the final analysis. Denosumab treatment significantly reduced the rate of osteolysis (p = 0.013). When denosumab was administered in combination with rhBMP-2, the fusion status remained similar; however, the incidences of postoperative osteolysis and postoperative oozing day decreased.
Conclusion The combined use of rhBMP-2 and RANKL inhibition in patients with bone density loss can enhance bone formation after PLIF with fewer complications than rhBMP-2 alone.
Citations
Citations to this article as recorded by
Postoperative bone loss after posterior lumbar interbody fusion is a risk factor of cage subsidence independently of preoperative CT-derived attenuation: a retrospective study based on hounsfield unit Yunsheng Wang, Ruiling Wang, Tong Tong, Dechao Miao, Feng Wang, Linfeng Wang BMC Musculoskeletal Disorders.2026;[Epub] CrossRef
Histomorphologic Assessment of Osteoregeneration in a Rabbit Femur Model With Xenograft, Bone Morphogenetic Protein-2, Platelet-Rich Plasma, and Denosumab Berik Tuleubayev, Yevgeniy Kamyshanskiy, Yerkin-Dauir Kurmangaliyev, Amina Koshanova, Ivan Avromidi, Yekaterina Kossilova, Daryn Darybayev Plastic and Reconstructive Surgery - Global Open.2026; 14(4): e7593. CrossRef
Comparable Fusion Response, but Increased Inflammatory Response, with Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 in Posterior Lumbar Interbody Fusion Surgery Mu Ha Lee, Hyun Jun Jang, Kyung Hyun Kim, Jeong-Yoon Park, Sung Uk Kuh, Dong Kyu Chin, Keun Su Kim, Jae Keun Oh, Bong Ju Moon Journal of Clinical Medicine.2026; 15(11): 4026. CrossRef
Comparison of Hounsfield Unit, Vertebral Bone Quality, and Dual-Energy X-Ray Absorptiometry T-Score for Predicting Cage Subsidence After Posterior Lumbar Interbody Fusion Yunsheng Wang, Jiali Zhang, Tong Tong, Dechao Miao, Feng Wang, Linfeng Wang Global Spine Journal.2025; 15(4): 2226. CrossRef
Antiosteoporosis medication in patients with posterior spine fusion: a systematic review and meta-analysis HyungSub Jin, HyungJu Jin, Kyung-Soo Suk, Byung Ho Lee, Si Young Park, Hak-Sun Kim, Seong-Hwan Moon, Sub-Ri Park, Namhoo Kim, Jae Won Shin, Ji-Won Kwon The Spine Journal.2025; 25(9): 1877. CrossRef
Impact of Frailty and Other Factors as Estimated by HU to Predict Response to Anabolic Bone Medications Abdelrahman M. Hamouda, Zach Pennington, Rahul Kumar, Michael L. Martini, Derrick Obiri-Yeboah, Maria Astudillo Potes, Nicholas Kendall, Anthony L. Mikula, Michelle J. Clarke, William E. Krauss, Ahmad N. Nassr, Brett A. Freedman, Arjun S. Sebastian, Melvi Journal of Clinical Medicine.2025; 14(9): 3247. CrossRef
Application of BMP-2 for bone regeneration in osteoporosis V.S. Kuznetsova, V.A. Sinelnikova, A.V. Vasilyev Stomatology.2025; 104(3): 101. CrossRef
Low-Dose Bone Morphogenetic Protein Use in Spinal Fusion : Rethinking Clinical Efficacy Jun Ho Lee, Ji Hyun Youn, Hyun Jung Park, Seung-Jae Hyun Journal of Korean Neurosurgical Society.2025; 68(6): 632. CrossRef
Promotion of Bone Formation in a Rat Osteoporotic Vertebral Body Defect Model via Suppression of Osteoclastogenesis by Ectopic Embryonic Calvaria Derived Mesenchymal Stem Cells Yerin Yu, Somin Lee, Minsung Bock, Seong Bae An, Hae Eun Shin, Jong Seop Rim, Jun-oh Kwon, Kwang-Sook Park, Inbo Han International Journal of Molecular Sciences.2024; 25(15): 8174. CrossRef
The Canal Bone Ratio Yunsheng Wang, Tong Tong, Jiali Zhang, Dechao Miao, Feng Wang, Linfeng Wang Spine.2024; 49(22): 1570. CrossRef
First
Prev
